Back to news and insights
Article

Is Your Anti-Bribery Strategy Effective?

February 13, 2014

Pharmaceutical Executive Global Digest -

The pharmaceutical sector needs re-address its anti-bribery policies and ensure that adequate measures are in place. Toby Duthie and David Lawler at Forensic Risk Alliance ask some searching questions about corruption in the sector and offer critical advice as the number of US and international enforcement actions continue to rise.

Read Full Article

No items found.
Article

FCPA Enforcement Update: Strategic Shift, Renewed Focus

June 19, 2025
Article

Mining Arbitrations and the Role of Specialised Experts in Valuation and Corruption

June 3, 2025
Webinar

On Demand | Mining Arbitrations: Navigating Valuation and Corruption Risks

June 19, 2025
Article

Décideurs Juridiques | Corruption Evidence in Arbitration - The Role of Red Flags

June 3, 2025